Atlas Trials

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Clinical trial NCT05474690 · WITHDRAWN

Trial details

NCT number
NCT05474690
Sponsor
Henan Cancer Hospital
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Breast CancerHER2-positive Breast Cancer
Start date
2022-05-11
Primary completion
2023-03-28
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.